发明申请
- 专利标题: Indazole compound and pharmaceutical use thereof
- 专利标题(中): 吲唑化合物及其药物用途
-
申请号: US10589130申请日: 2005-02-10
-
公开(公告)号: US20070173537A1公开(公告)日: 2007-07-26
- 发明人: Akihiro Takemiya , Masahiro Nakajo , Hisae Oshima , Tomotaka Yanagi , Mami Mochizuki , Hideo Nakamura
- 申请人: Akihiro Takemiya , Masahiro Nakajo , Hisae Oshima , Tomotaka Yanagi , Mami Mochizuki , Hideo Nakamura
- 申请人地址: JP Osaka-shi 541-0046
- 专利权人: Mitsubishi Pharma Corporation
- 当前专利权人: Mitsubishi Pharma Corporation
- 当前专利权人地址: JP Osaka-shi 541-0046
- 优先权: JP2004-035565 20040212
- 国际申请: PCT/JP05/01996 WO 20050210
- 主分类号: A61K31/415
- IPC分类号: A61K31/415 ; C07D231/56
摘要:
The present invention can provide a cancer treatment drug containing, as an active ingredient, a substance selected from the group consisting of an indazole compound of the following formula (I), a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate:
公开/授权文献
- US07994196B2 Indazole compound and pharmaceutical use thereof 公开/授权日:2011-08-09
信息查询